Press Releases

March 10, 2014 • 6:00 AM EDT

Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC

March 6, 2014 • 7:24 AM EST

Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity

March 3, 2014 • 12:00 PM EST

Amarantus Outlines MANF Research Collaboration Strategy

February 24, 2014 • 7:12 AM EST

Amarantus Strengthens Management Team With Key Additions in Business Development and Regulatory Affairs

February 19, 2014 • 7:15 AM EST

CEO Gerald Commissiong of Amarantus to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW 1190AM

February 18, 2014 • 6:00 AM EST

Amarantus Bioscience Holdings Announces $3M Solicitation of Previously Issued Warrants

February 6, 2014 • 9:00 AM EST

Amarantus to Present at 16th Annual BIO CEO & Investor Conference

February 4, 2014 • 8:30 AM EST

Amarantus Announces Positive Phase 2a Data for Eltoprazine in Adult ADHD

January 29, 2014 • 7:30 AM EST

Amarantus Establishes LymPro Research Collaboration With Boston University School of Medicine

January 27, 2014 • 10:37 PM EST

ESPN's Andrew Brandt Final Addition to #C4CT Concussion Awareness Summit